ONCO Oncology Med Inc.
-
Oncology Med Reported Earnings
Thursday, August 13, 2026 · 12:00 AM ET
Oncology Med (ONCO) reported a loss of $1.28 per share on revenue of $0.02 million for the . . Revenue fell 84.11% compared to the same quarter a year ago.
Onconetix Inc. is a commercial stage biotechnology company focused on the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. Onconetix Inc., formerly known as Blue Water Biotech Inc., is based in CINCINNATI.
Earnings Whisper Grade
—
Power Rating—
Reported Earnings
($1.28)
Earnings Whisper®
—
Consensus Estimate
—
Earnings Surprise
Earnings Growth
Reported Revenue
$0.02M
Revenue Estimate
—
Revenue Surprise
Revenue Growth